ASTMH 2018

67th Annual Meeting

28 October – 1 November 2018
New Orleans, USA

  • Nathalie Strub-Wourgaft, NTD Director – presentation on fexinidazole in a symposium on sleeping sickness elimination
  • Colin Forsyth, Chagas Epidemiologist, Sergio Sosa Estani, Head of Chagas Clinical Programme, Eric Chatelain, Head of Drug Discovery Programme – symposium on screening and diagnosis of Chagas disease
  • Poster and oral presentations on sleeping sickness, visceral leishmaniasis, Chagas, onchocerciasis, and mycetoma

DNDi announces new Director of Neglected Tropical Diseases

Former DNDi Medical Director Dr Nathalie Strub-Wourgaft takes over leadership of NTD programme

DNDi is pleased to announce the appointment of Dr Nathalie Strub-Wourgaft as the new Director of Neglected Tropical Diseases. She will assume her new role as NTD Director and member of DNDi’s Executive Team as of 1 July 2018.

Onchocerciasis Network Meeting

3-4 October 2018
Kampala, Uganda

  • Sabine Specth, Head of Filariasis Clinical Programme – presentation of unmet medical need of onchocerciasis patients and Target Product Profile
  • Belén Pedrique, Medical Manager – presentation on access strategies for new treatments for onchocerciasis
  • Florent Mbo, HAT Platform Coordinator – presentation of the HAT Platform

ISNTD 2018

25-26 June 2018 
London, UK
Ivan Scandale, Senior Project Manager, Discovery – presentation on the filarial research landscape
Eric StobbaertsInternational Development Director – presentation on access to Chagas treatments in Latin America

Geneva Health Forum

7th Edition: Precision Global Health in the Digital Age

10-12 April 2018
Geneva, Switzerland
Bernard Pécoul, Executive Director – plenary talk on emerging infectious diseases crisis
Digas Ngolo, Investigator Coordinator, DNDi Africa – parallel session on ehealth

DNDi reçoit le Prix 2017 de l’Innovation à Genève pour récompenser son action en faveur des populations les plus négligées

A l’occasion de l’Evénement économique 2017 du 9 novembre dernier, la Chambre de commerce, d’industrie et des services de Genève (CCIG), le Département de la sécurité et de l’économie (DSE) et l’Office de Promotion des Industries et des Technologies (OPI) ont décerné le Prix 2017 de l’innovation à l’initiative Médicaments contre les Maladies Négligées (DNDi).

ASTMH 2017

November 5-9, 2017
Baltimore, Maryland, USA
DNDi took part in symposia, poster and oral presentation sessions at the meeting.